Fundraising Fox

Timothy Haines

Investor

Managing Partner at Abingworth

London

Writes $15M – $30M checks · typically $22.5M

About

Tim Haines has over 40 years of international management experience in life sciences across public and private companies. He joined Abingworth in 2005 as a Partner and later served as Chairman and Managing Partner; before that he was the founding CEO of Abingworth portfolio company Astex Therapeutics, which was acquired by Otsuka Pharmaceuticals. Earlier roles include CEO of two divisions of Datascope Corp, CEO of Thackray Inc, and General Manager of Baxter UK. He holds a BSc from Exeter University and an MBA from INSEAD.

LinkedIn ↗

Invests in

Biotech

Experience

  1. TenUChaircurrent2024 — presentGreater London
  2. IMU BiosciencesNon Executive Chaircurrent2024 — presentLondon, England, United Kingdom
  3. AbingworthManaging Director and Executive Partnercurrent2023 — presentLondon, England, United Kingdom
  4. AbingworthManaging Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.2022 — 2023London, England, United Kingdom
  5. AbingworthChairman and Managing Partner2019 — 2022London, United Kingdom
  6. AbingworthManaging Partner2015 — 2019London, United Kingdom
  7. AbingworthPartner2005 — 2015London, United Kingdom
  8. Oxford University InnovationAdvisory Board Membercurrent2022 — present
  9. Wellcome TrustPanel Member - Health Innovation Challenge Fund2009 — 2014
  10. Astex PharmaceuticalsCEO2000 — 2005Greater Cambridge Area
  11. DatascopeCEO Intervascular Inc. and Patient Monitoring1993 — 2000France / USA
  12. Telectronics Pacing Systems, Inc.General Manager / VP R and D and Manufacturing1990 — 1993Paris / US
  13. Thackary Orthopedic Inc.CEO1987 — 1990USA
  14. Baxter International Inc.General Manager1983 — 1987UK

Education

  1. INSEADMaster of Business Administration (MBA), Business Administration and Management1982 — 1983
  2. Harvard Business SchoolStrategic Marketing Course
  3. University of ExeterBSc Hons

Skills & more

Strategy1Private Equity3Venture Financing2Angel InvestingPrivate PlacementsLBO1IPO1M&A experienceGrowth Capital4Mergers & Acquisitions3Business Development8Biotechnology10
+8 moreVenture CapitalManufacturingMedical DevicesCorporate DevelopmentCapital RaisingEntrepreneurshipBusiness StrategyStart-ups

Languages French

From Timothy's professional profile.

Same school

Also attended INSEAD697

Patrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesStephane KurganInvestor at Index VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures

+ 691 more

Also attended Harvard Business School1,818

Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins

+ 1,812 more

Also attended University of Exeter86

Tom McGinnGeneral Counsel at NorthzoneAlexandra FarmerFund Accountant at NorthzoneElsa Backdahl NordenfalkSenior Director of Capital Formation at Pantera CapitalGiles Johnstone-ScottInvestor at MedicxiHector MasonGeneral Partner at Episode1Stephen ChandlerManaging Partner at Notion Capital

+ 80 more

Shared employers

Also worked at IMU Biosciences3

Mohadeseh AbdullahiPartner at Giant Ventures Global LlpCarlos PayaVenture Partner at Ysios CapitalInga DeakinPrincipal at Molten Ventures

Also worked at Abingworth17

Carlos PayaVenture Partner at Ysios CapitalSarah ShackeltonAdvisor at Delin VenturesBali MuralidharGlobal Head of Life Sciences & CIO at AbingworthKurt von EmsterManaging Partner at AbingworthJayson PunwaniManaging Director, Head of Venture at AbingworthAndrew SinclairManaging Director, Head of Publics & Late Stage at Abingworth

+ 11 more

Also worked at Wellcome Trust8

Yusuf SherwaniCo-Founder and CEO at Pelago; a Londoner living in New York CityMohadeseh AbdullahiPartner at Giant Ventures Global LlpCharles SpicerNon-Executive Chair at EMV CapitalFreddie DearPrincipal at Monograph Capital PartnersSarah HardyDirector, Head of New Investments at ArchangelsJoseph AndersonPartner, Crossover Strategy at Sofinnova Partners

+ 2 more

Also worked at Astex Pharmaceuticals1

R G BoyleIndependent Representative of the Investment Advisory Panel at O2h Ventures

Investments

Board seats

Adaptate BiotherapeuticsAntaresAstexFoveaGammaDelta TherapeuticsHBIMEDIAN TechnologiesPowderMedScorpionSientraStanmoreVenatorx

Per the firm's website.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth